Charles River Laboratories | CRL - Umsatzkosten

Aktienkurs
154.24
Täglich Wechseln
1.81 1.19%
Monatlich
-15.76%
Jährlich
14.27%
Q2 Prognose
147.82




Umsatzkosten Veränderung Datum
Agilent USD 852M 19M 2025-12
Align Technology USD 303.5M 60.47M 2026-03
Bio-Rad Laboratories USD 348M 38.4M 2025-12
Bruker USD 443.6M 84.4M 2026-03
Cardinal Health USD 58.54B 4.82B 2026-03
Charles River Laboratories USD 716.51M 5.76M 2026-03
Cigna USD 62.41B 4.1B 2026-03
Concord Medical Services Hldg CNY 204.9M 117.04M 2025-06
CVS Health USD 84.8B 7.32B 2026-03
Danaher USD 2.36B 512M 2026-03
Dentsply International USD 453M 65M 2026-03
Elevance Health USD 38.07B 75M 2025-12
Humana USD 26.54B 1.15B 2025-03
Illumina USD 370M 30M 2026-03
Incyte USD 104.5M 16.68M 2026-03
Intrexon USD 1.01M 344K 2024-06
IQVIA Holdings USD 3.08B 161M 2026-03
Laboratory Of America USD 2.6B 4.2M 2026-03
Lakefront Biotherapeutics EUR 4.8M 4.34M 2026-03
Lonza CHF 2.28B 189M 2025-06
McKesson USD 92.25B 10.22B 2026-03
Merck EUR 2.07B 219M 2026-03
Mettler Toledo International USD 410.92M 63.05M 2026-03
Novartis USD 3.46B 83M 2026-03
Pfizer USD 4.59B 1.7B 2026-03
Quest Diagnostics USD 1.99B 57M 2026-03
Revvity USD 323.46M 26.93M 2026-03
Thermo Fisher Scientific USD 6.96B 620M 2026-03
United Therapeutics USD 133.4M 341.3M 2026-03
UnitedHealth USD 94.72B 2.2B 2025-12
Veradigm USD 124.74M 56.25M 2022-12
Waters USD 725M 350.06M 2026-03
West Pharmaceutical Services USD 548.5M 47.4M 2026-03